The constitutive activation of ROS1 fusion proteins drives oncogenesis in NSCLC via multiple signaling cascades, primarily the PI3K/AKT, MAPK/ERK, and STAT3 pathways [8,9]. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.